Skip to content
Search

Latest Stories

Gen-Z prefers Pharmaceuticals over Tech and Finance, new ABPI report reveals

Gen-Z prefers Pharmaceuticals over Tech and Finance, new ABPI report reveals
The ABPI report also notes a strong attraction to the pharmaceutical industry among those with STEM backgrounds

In a significant shift, younger workers are increasingly choosing careers in the pharmaceutical industry over traditional sectors like finance and technology, a new research study by the Association of the British Pharmaceutical Industry (ABPI) has highlighted.

Driven by perceptions of better work-life balance and a greater sense of social purpose associated with pharmaceuticals, the report titled Young People's Perceptions of Careers in the Pharmaceutical Industry, highlighted motivations behind young people's career choices.


While a good salary continues to be the leading factor influencing career decisions for young people, with 50 per cent of respondents citing it as their primary concern, 28 percent said work-life balance, only 23 per cent said engaging work and job security (20 per cent) are significant considerations for job seekers.

According to the report, young people rate the pharmaceutical sector higher in terms of positive contributions to society compared to technology, 54 per cent and 23 per cent, respectively, and finance (53 per cent vs. 25 per cent ), and energy (53 per cent vs. 20 percent).

Andrew Croydon, Director of ABPI Education and Examination Policy & Partnerships, commented on these findings, emphasising the need for industries to adapt to changing preferences.

"As the workforce landscape continues to evolve, it's crucial for industries like ours to adapt to the changing preferences of the generations to come.

"By offering competitive salaries, promoting work-life balance, and highlighting the societal impact of their work, companies can attract and retain top talent in this competitive market," Croydon said.

The report also reveals a consistent trend across various demographic groups, indicating that regardless of gender, age, education, or financial background, young professionals prioritise earnings, work-life balance, job security, and engaging work.

This consistency highlights the universal appeal of these job attributes among young professionals.

However, the report points out that the pharmaceutical industry still faces challenges.

Many young people are unaware of the diverse range of opportunities within the industry and the various routes of entry available.

Although the number of life sciences apprenticeships has been steadily increasing, this lack of understanding contributes to perceptions of narrow career pathways and limited diversity.

To address these challenges, the ABPI report offers actionable recommendations for industry leaders including transparent salary benefits, industry awareness, and clear job requirements.

The report also notes a strong attraction to the pharmaceutical industry among those with STEM (Science, Technology, Engineering, and Mathematics) backgrounds.

Recent statistics from the Office for Life Sciences show that the UK has a high proportion of graduates completing STEM courses, ranking second behind India in 2021.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less